cb-quinones hu-311 (MultiTarget Pharmaceuticals)
90
Structured Review
MultiTarget Pharmaceuticals
cb-quinones hu-311
Cb Quinones Hu 311, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/point+cloud+multitarget+tracking+algorithm/cb+quinones+hu+311/pmc07502221-160-34-34
Average 90 stars, based on 1 article reviews
Cb Quinones Hu 311, supplied by MultiTarget Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/point+cloud+multitarget+tracking+algorithm/cb+quinones+hu+311/pmc07502221-160-34-34
Average 90 stars, based on 1 article reviews
cb-quinones hu-311 - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Novel approaches and current challenges with targeting the endocannabinoid system"
Article Title: Novel approaches and current challenges with targeting the endocannabinoid system
Journal: Expert opinion on drug discovery
doi: 10.1080/17460441.2020.1752178
Figure Legend Snippet: Structure of allosteric cannabinoids: ORG27759, ORG29647, GAT211, ZCZ011, PSNCBAM-1, lipoxin A4, pregnenolone, RTI-371, DHGA, trans-β-caryophyllene and structure of the agonist CB1/CB2 CP55,940.
Techniques Used:
Figure Legend Snippet: Structure of pheripheral cannabinoids: AM6545, TM38837, PrNMI, TXX522, LEI-101, DBPR211.
Techniques Used:
![Structure of multitarget cannabinoids: CB-quinones HU-311 [71], VCE-004.8 and VCE-003.2 [67,68] and chromenopyrazolediones 4 and 10 [69,70]; indazolylketones 5 and 6 [75]; diarylpyrazole derivative 4 [76]; 1,2-dihydro-2-oxo-pyridine-3-carboxamide B1 [77] and CB-opioid bivalent ligands 11 and 19 [86]. Numbers that have been attributed to the structures refer to the corresponding number in original articles.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_2221/pmc07502221/pmc07502221__nihms-1628248-f0004.jpg "Structure of multitarget cannabinoids: CB-quinones HU-311 [71], VCE-004.8 and VCE-003.2 [67,68] and ...")
Figure Legend Snippet: Structure of multitarget cannabinoids: CB-quinones HU-311 [71], VCE-004.8 and VCE-003.2 [67,68] and chromenopyrazolediones 4 and 10 [69,70]; indazolylketones 5 and 6 [75]; diarylpyrazole derivative 4 [76]; 1,2-dihydro-2-oxo-pyridine-3-carboxamide B1 [77] and CB-opioid bivalent ligands 11 and 19 [86]. Numbers that have been attributed to the structures refer to the corresponding number in original articles.
Techniques Used:
Figure Legend Snippet: Structure of endocannabinoids virodhamine, noladin ether, oleylethanolamide and palmitoylethanolamide; putativee endogenous ligands for GPR55 and GPR18 LPI and NAGly; and synthetic cannabinoids HU210, JWH133, O-1602, Abn-CBD, SR141716A and SR144528.
Techniques Used:
Figure Legend Snippet: Summary of potential approaches to target the ECS. A) Modulation at CB1 and CB2 receptors (G-prot refers to G protein signaling and β-arr to β-arrestin1 or 2 pathways). B) Other targets of cannabinoids.
Techniques Used:
Related Articles
other:Article Title: Novel approaches and current challenges with targeting the endocannabinoid system Article Snippet: The neuroprotective effects of this molecule were proved to be mediated by activation of PPAR-γ. fig ft0 fig mode=article f1 fig/graphic|fig/alternatives/graphic mode="anchored" m1 Open in a separate window Figure 4. |